Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 2
2003 3
2004 4
2005 2
2006 4
2007 2
2008 7
2009 7
2010 9
2011 6
2012 5
2013 8
2014 11
2015 13
2016 18
2017 12
2018 10
2019 16
2020 18
2021 23
2022 13
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers.
Schwarze JE, Venetis C, Iniesta S, Falla E, Lukyanov V, de Agustin Calvo E, D Hooghe T, Roeder C, Matorras R. Schwarze JE, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):203-216. doi: 10.1016/j.bpobgyn.2022.01.011. Epub 2022 Feb 8. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35227619 Free article. Review.
This study compared the cost per live birth and cost-effectiveness of the originator recombinant human follicle-stimulating hormone follitropin alfa (r-hFSH-alfa) and r-hFSH-alfa biosimilars for ovarian stimulation prior to assisted reproductive technology treatment …
This study compared the cost per live birth and cost-effectiveness of the originator recombinant human follicle-stimulating hormone folli …
XM17 Follitropin Alfa (Ovaleap()): A Review in Reproductive Endocrine Disorders.
Hoy SM. Hoy SM. BioDrugs. 2016 Aug;30(4):379-86. doi: 10.1007/s40259-016-0183-4. BioDrugs. 2016. PMID: 27342604 Review.
In a nonblind, phase I study in healthy female volunteers, the pharmacokinetic profile of XM17 follitropin alfa was bioequivalent to that of reference follitropin alfa following single dosing. ...Thus, XM17 follitropin alfa is an effectiv …
In a nonblind, phase I study in healthy female volunteers, the pharmacokinetic profile of XM17 follitropin alfa was bioequival …
Lutropin alfa.
Dhillon S, Keating GM. Dhillon S, et al. Drugs. 2008;68(11):1529-40. doi: 10.2165/00003495-200868110-00005. Drugs. 2008. PMID: 18627209 Review.
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonadotropic hypogonadism and profound LH deficiency (<1.2 IU/L) who received subcutaneous lutropin alfa 0-225 IU/day plus follitropin …
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonad …
Biosimilars versus the originator of follitropin alfa: Randomized controlled trials are still the best way to evaluate their comparative effectiveness in assisted reproduction.
Venetis CA, Mol BW. Venetis CA, et al. Drug Discov Today. 2023 Feb;28(2):103425. doi: 10.1016/j.drudis.2022.103425. Epub 2022 Nov 1. Drug Discov Today. 2023. PMID: 36332833
Biosimilars of follitropin alfa have been introduced in many countries as more affordable alternatives to the reference product for patients undergoing ovarian stimulation for assisted reproductive technology cycles. A recent meta-analysis, by reviewing available ev …
Biosimilars of follitropin alfa have been introduced in many countries as more affordable alternatives to the reference produc …
Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
Saz-Parkinson Z, López-Cuadrado T, Bouza C, Amate JM. Saz-Parkinson Z, et al. BioDrugs. 2009;23(1):37-42. doi: 10.2165/00063030-200923010-00004. BioDrugs. 2009. PMID: 19344190 Review.
Several clinical trials have tried to assess the clinical implications of the physicochemical improvements in the dosing of follitropin alfa filled by mass (FbM). The aim of this study was to perform a meta-analysis of previous studies in order to assess the efficac …
Several clinical trials have tried to assess the clinical implications of the physicochemical improvements in the dosing of follitropin …
In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta.
Haakman O, Liang T, Murray K, Vilos A, Vilos G, Bates C, Watson AJ, Miller MR, Abu-Rafea B. Haakman O, et al. F S Rep. 2020 Dec 14;2(1):30-35. doi: 10.1016/j.xfre.2020.12.002. eCollection 2021 Mar. F S Rep. 2020. PMID: 34223270 Free PMC article.
Cycles were grouped on the basis of stimulation with follitropin delta vs. follitropin alfa or beta. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Embryo parameters and clinical pregnancy and implantation rates. ...CONCLUSIONS: Stimulation with follitropin delta in IV …
Cycles were grouped on the basis of stimulation with follitropin delta vs. follitropin alfa or beta. INTERVENTIONS: None. MAIN …
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC; ESTHER-1 study group. Nyboe Andersen A, et al. Fertil Steril. 2017 Feb;107(2):387-396.e4. doi: 10.1016/j.fertnstert.2016.10.033. Epub 2016 Nov 29. Fertil Steril. 2017. PMID: 27912901 Free article. Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of follitropin delta, a new human recombinant FSH with individualized dosing based on serum antimullerian hormone (AMH) and body weight, with conventional follitropin alfa dosing for ovarian stimulation in women undergoi …
OBJECTIVE: To compare the efficacy and safety of follitropin delta, a new human recombinant FSH with individualized dosing based on serum an …
183 results